Skip to content
I-OnAsia
Trusted Due Diligence, Corporate Investigations & Litigation, & Crisis Management Service
I-OnAsia
  • Home
  • Services
    • Due Diligence
      • Pre-IPO Due Diligence Market Leaders
      • SPAC Background Checks & De-SPAC Due Diligence
      • Enhanced Due Diligence
    • Corporate Investigations & Litigation
      • White Collar Investigations & Defence
      • Fraud & Corruption Investigations
      • Global Asset Tracing
      • Global Skip Trace & People Locate Services
      • Writ Services
      • Digital Forensics & Electronic Discovery
      • Brand Protection & Anti-Dumping
    • Security Consultancy
      • Information Security & TSCM “Bug Sweeps”
      • Elite Individuals & Families
      • Threat Intelligence
      • Rapid Response In Hong Kong
  • Leadership Team
  • Blog
  • Locations
    • Hong Kong & Greater China
    • New York & Americas
    • London & EMEA
    • Sydney & Australia
  • Contact
  • Menu iconZH
Search:
  • Home
  • Services
    • Due Diligence
      • Pre-IPO Due Diligence Market Leaders
      • SPAC Background Checks & De-SPAC Due Diligence
      • Enhanced Due Diligence
    • Corporate Investigations & Litigation
      • White Collar Investigations & Defence
      • Fraud & Corruption Investigations
      • Global Asset Tracing
      • Global Skip Trace & People Locate Services
      • Writ Services
      • Digital Forensics & Electronic Discovery
      • Brand Protection & Anti-Dumping
    • Security Consultancy
      • Information Security & TSCM “Bug Sweeps”
      • Elite Individuals & Families
      • Threat Intelligence
      • Rapid Response In Hong Kong
  • Leadership Team
  • Blog
  • Locations
    • Hong Kong & Greater China
    • New York & Americas
    • London & EMEA
    • Sydney & Australia
  • Contact
  • Menu iconZH

May 27, 2020

You are here:
  1. Home
  2. 2020
  3. May
  4. 27
May272020

COO’s Assessment that Exam Cheating + Pre-Revenue Biotech = Fraud Concerns

UncategorizedMay 27, 2020

One of the biggest potential challenges for investors in pre-revenue biotech companies preparing to IPO in Hong Kong may be…

Read more
May272020

COO’s Briefing on Crisis Communications (Presentation to SCCE)

UncategorizedMay 27, 2020

I-OnAsia’s COO James Tunkey has been asked to present to the Society of Corporate Compliance and Ethics on October 25th…

Read more
May272020

CEO’s Ruminations: Risk Advisors Open In Canada

UncategorizedMay 27, 2020

As I put my chubby thumbs and forefingers to keys, I could not avoid ruminating about The Donald’s never-ending tweet-screaming…

Read more
May272020

CEO’s Ruminations: On (Anti) Money Laundering

UncategorizedMay 27, 2020

While celebrating or bemoaning (depending upon your perspective) the resumption of sovereignty or handover or takeover of Hong Kong to…

Read more
May272020

COO’s Briefing to Law Enforcement (NYC’s Retired FBI Agents)

UncategorizedMay 27, 2020

I-OnAsia’s Chief Operating Officer provided a briefing to New York Chapter of The Society of Former FBI Agents at a…

Read more
May272020

CEO’s Ruminations: Pre-IPO Due Diligence

UncategorizedMay 27, 2020

I apologize profusely to those of you who tinkled regarding my failure to ruminate, at least publicly, over the last…

Read more
←12345→

Get in touch

Hong Kong & Greater China : (+852) 2896-4489

New York & Americas : +1 (917) 608 3476

London & EMEA : +44 792 8888 886

Contact I-OnAsia
© 2001– 2026 I-OnAsia Limited. All rights reserved. | Privacy Policy
Go to Top